芙瑞 2.5mg Letrozol Tablets Drugs Reference Listed Drug Marketed in China

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic name	Letrozol Tablets
Trade name	芙瑞
Specification	2.5mg
Main ingredients	Letrozol
Appearance	This product is white or almost white tablet.
Manufacturer	Jiangsu Hengrui Pharmaceutical Co., Ltd             江苏恒瑞医药股份有限公司

Indications:

 

It is used for adjuvant therapy for postmenopausal patients with early breast cancer who are estrogen or progesterone receptor positive. 

Adjuvant therapy for postmenopausal women with early breast cancer who have received tamoxifen adjuvant therapy for 5 years and are estrogen or progesterone receptor positive.

 

To treat postmenopausal women with advanced breast cancer, estrogen receptor positive progesterone receptor positive or unknown receptor status. These patients should undergo natural menopause or artificially induced menopause.

 

 

 

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

 

 

Hot Tags: 芙瑞 2.5mg Letrozol Tablets Drugs Reference Listed Drug Marketed in China, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Bimatoprost Ophthalmic, Argatroban Injection, Phenytoin Sodium Tablets, Reference Listed Drugs, Esomeprazole Magnesium Enteric Coated Capsules, AdapaleneGel

• Previous: Fareston 60mg Toremifene Citrate Tablets Reference Listed Drug
• Next: Remeron 30mg Mirtazapine Tablets Chinese Comparator Drug